Available
Shipped to France : 0.01€
(for any order > 35€)

Pages: 80
Format: 17 x 24 cm
ISBN : 978-2-7420-1633-4
ISBN élec : 978-2-7420-1655-6
Printed in: English
Publication date: 14/01/2021

There has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy.

A number of studies were published during the last 5 years demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes.

This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and long-term effects on development and behaviour. Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of

drug-resistant epilepsies.

Alexis Arzimanoglou, Paediatric Clinical Epileptology, Sleep Disoorders and Functional Neurology Department, University Hospitals of Lyon, France and Hospital San Juan de Dios Children’s Hospital, Barcelona, Spain, Members of the ERN EpiCARE

Ulrich Brandl, Department of Neuropediatrics, University Hospital Jena, Jena, Germany

Helen J. Cross, UCL-Institute of Child Health, Great Ormond Street Hospital for Children, Member of the European Reference Network EpiCARE, London & Young Epilepsy, Lingfi eld, UK

Antonio Gil-Nagel, Epilepsy Program, Neurology Department, Hospital Ruber Internacional, Madrid, Spain

Lieven Lagae, Paediatric Neurology, UZ Leuven, Member of the European Reference Network EpiCARE, Leuven, Belgium

Cecilie Johannessen Landmark, Programme for Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, and The National center for epilepsy and Dpt of Pharmacology, Oslo University Hospital, Norway

Nicola Specchio, Rare and Complex Epilepsy Unit, Department of Neurosciences, Bambino Gesù Children’s Hospital, IRCCS, Member of the European Reference Network EpiCARE, Rome, Italy

Elizabeth A. Thiele, Department of Neurology, Massachusetts General Hospital, Boston, USA

We recommand